Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Fabry Disease
Related studies linked through entity extraction aliases.
Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.
- Status
- COMPLETED
- Phase
- PHASE4
Extension Study of PRX-102 for up to 60 Months
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.
- Status
- COMPLETED
- Phase
- NA
A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
- Status
- TERMINATED
- Phase
- PHASE1
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer.
- Status
- UNKNOWN
- Phase
- N/A
Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluate the Safety and Exploratory Efficacy of GC1119
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
- Status
- COMPLETED
- Phase
- PHASE4
Pulmonary Involvement in Patients With Fabry Disease
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
- Status
- RECRUITING
- Phase
- N/A
Migalastat Food Effect Study
- Status
- COMPLETED
- Phase
- PHASE1
Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease
- Status
- AVAILABLE
- Phase
- N/A
Open-Label Phase 3 Long-Term Safety Study of Migalastat
- Status
- TERMINATED
- Phase
- PHASE3
Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur
- Status
- COMPLETED
- Phase
- NA